Effects of chemotherapy on bone metabolism and skeletal growth

Hormone Research

Volumn 58, Issue SUPPL. 1, 2002, Pages 80-85

  Siebler, Thomas ^a   Shalet, S M ^b   Robson, H ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bone; Chemotherapy; Chondrocytes; Growth; Survivors of cancer treatment

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOCORTICOID;

APOPTOSIS; BONE CELL; BONE GROWTH; BONE METABOLISM; CANCER CHEMOTHERAPY; CARTILAGE CELL; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CHILDHOOD CANCER; CONFERENCE PAPER; DRUG MECHANISM; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GROWTH PLATE; HUMAN; HYPERTROPHY; LONG BONE; OSTEOPOROSIS; PRIORITY JOURNAL; SHORT STATURE;

ANTINEOPLASTIC AGENTS; BODY HEIGHT; BONE AND BONES; BONE DEVELOPMENT; CHILD; CHONDROCYTES; GLUCOCORTICOIDS; GROWTH PLATE; HUMANS; NEOPLASMS; OSTEOPOROSIS;

EID: 0036426993     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064769     Document Type: Conference Paper

References (35)

1. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS: Recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999;91:1051-1058.
2. Olshan JS, Gubernick J, Packer RJ, et al: The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 1992;70:2013-2017.
3. Pockwinse SM, Stein JL, Lian JB, Stein GS: Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: Interrelationship of morphology and gene expression by in situ hybridization. Exp Cell Res 1995;216:244-260.
4. Shalet SM, Whitehead E, Chapman AJ, Beardwell CG: The effects of growth-hormone therapy in children with radiation-induced growth-hormone deficiency. Acta Paediatr Scand 1981;70:81-86.
5. Lannering B, Albertsson-Wikland K: Improved growth-response to GH treatment in irradiated children. Acta Paediatr Scand 1989;78:562-567.
6. Ogilvy-Stuart AL, Shalet SM: Growth and puberty after GH treatment after irradiation for brain tumours. Arch Dis Child 1995;73:141-146.
7. Glasser DB, Duane K, Lane JM, Healey JH, Caparros-Sison B: The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop 1991;262:93-100.
8. Holm K, Nysom K, Hertz H, Muller J: Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr 1994;83:1287-1290.
9. Ahmed SF, Wallace WH, Kelnar CJ: An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res 1997;48:178-183.
10. Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ: Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol 1991;9:400-405.
11. Thun-Hohenstein L, Frisch H, Schuster E: Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma. Horm Res 1992;37:91-95.
12. Caruso-Nicoletti M, Mancuso M, Spadaro G, Dibenedetto SP, DiCataldo A, Schiliro G: Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia. Eur J Pediatr 1993;152:730-733.
13. Kirk JA, Raghupathy P, Stevens MM, et al: Growth failure and growth hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987;i:190-193.
14. Clayton PE, Shalet SM, Morris-Jones PH, Price DA: Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988;i:460-462.
15. Mohnike K, Dorffel W, Timme J, et al: Final height and puberty in 40 patients after anti-leukaemic treatment during childhood. Eur J Pediatr 1997;156:272-276.
16. Crofton PM, Ahmed SF, Wade JC, et al: Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1998;83:3121-3129.
17. Samuelsson BO, Marky I, Rosberg S, Albertsson-Wikland K: Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma. Med Pediatr Oncol 1997;28:27-34.
18. Nivot S, Benelli C, Clot JP, Saucet C, Adan L, Souberbielle JC, Zucker JM, Rappaport R, Brauner RJ: Nonparallel changes of growth hormone (GH) and insulin-like growth factor-1, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy. Clin Endocrinol Metab 1994;78:597-601.
19. Bar-On E, Beckwith JB, Odom LF, Eilert RE: Effect of chemotherapy on human growth plate. J Pediatr Orthop 1993;13:220-224.
20. Robson H: Bone growth mechanisms and the effects of cytotoxic drugs. Arch Dis Child 1999; 81:360-364.
21. Van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ: The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 2000; 26:363-376.
22. Shapiro IM, Mansfield KD, Evans SM, Lord EM, Koch CJ: Chondrocytes in the endochondral growth cartilage are not hypoxic. Am J Physiol 1997;272:C134-C143.
23. Morris MJ: In Vitro Effects of Anti-leukaemic Drugs on Cartilage Metabolism and their Effects on Somatomedin Production by the Liver; PhD thesis, Manchester 1981.
24. Robson H, Anderson E, Eden OB, Isaksson O, Shalet SM: Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation. J Endocrinol 1998;157:225-235.
25. Van der Veen MJ, Scheven BAA, Van Roy JLAM, Damen CA, Lafeber FPJG, Bijlsma JWJ: In vitro effects of methotrexate on human articular cartilage and bone derived osteoblasts. Br J Rheumatol 1996;35:342-349.
26. Van Leeuwen BL, Kamps WA, Hartel RM, Veth RP, Sluiter WJ, Hoekstra HJ: Effect of single chemotherapeutic agents on the growing skeleton of the rat. Ann Oncol 2000;11:1121-1126.
27. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr: Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 1992;263:E489-E492.
28. Silvestrini G, Ballanti P, Patacchioli FR, Mocetti P, Di Grezia R, Wedard BM, Angelucci L, Bonucci E: Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000;26:33-42.
29. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE: The localization of the functional glucocorticoid receptor α in human bone. J Clin Endocrinol Metab 2000;85:883-889.
30. Jux C, Leiber K, Hugel U, et al: Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-1 production and expression of GH and IGF-1 receptor in cultured rat chondrocytes. Endocrinology 1998;139:3296-3305.
31. Altman A, Hochberg Z, Silbermann M: Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse. Calcif Tissue Int 1992;51:298-304.
32. Robson H, Anderson E, Eden OB, Isaksson O, Shalet SM: Growth plate chondrocytes remain responsive to both IGF-1 and GH following treatment with chemotherapeutic agents. Horm Res 1998;50(suppl 3):O33.
33. Annefeld M: Changes in rat epiphyseal cartilage after treatment with dexamethasone and glycosaminoglycan-peptide complex. Pathol Res Pract 1992;188:649-652.
34. Sekiya I, Koopman P, Tsuji K, Mertin S, Harley V, Yamada Y, Shinomiya K, Nifuji A, Noda M: Dexamethasone enhances Sox-9 expression in chondrocytes. J Endocrinol 2001; 169:573-579.
35. Allen DB: Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am 1996;25:699-717.